Advocacy in Action: PFA Special Report - Reimbursement and Policy Considerations

Поделиться
HTML-код
  • Опубликовано: 30 сен 2024
  • In this episode of Advocacy in Action, #HRStv host Daniel M. Alyesh, MD, FHRS, sits down with Christopher F. Liu, MD, FHRS, to discuss the following:
    • FDA approval of PFA and regulatory challenges around reimbursement and costs of care.
    • Concerns about PFA for AFib being applied outside the practice of electrophysiology.
    • The potential for improved outcomes with PFA and which outcomes deserve most emphasis.
    #PFA #AFib #Ablation #CMS #Reimbursement

Комментарии • 2

  • @TimJackson1975
    @TimJackson1975 5 месяцев назад +1

    Kudos to Dr. Liu and all heart rhythm doctors for continuing to fight on behalf of patients, not health insurance, medical device / pharma, or health system conglomerate companies!

  • @lrc87290
    @lrc87290 4 месяца назад

    What can we learn from Europe which has been doing FaraPulse for over a yr. with more than 40,000 procedures completed?